Contemporary Issues in Lung CancerJones & Bartlett Publishers, 2009 M02 12 - 364 pages In the United States, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death. Even more devastating is its five-year survival rate of only 15.8%. Despite these dismal facts, lung cancer receives little national attention and research and funding for lung cancer lags behind other cancers. The intent of Contemporary Issues in Lung Cancer: A Nursing Perspective Second Edition is to provide oncology nurses and healthcare professionals with in-depth information on the issues that surround this disease, so that they might impact both education and research and provide better care for their patients. |
From inside the book
Results 1-5 of 90
Page ix
... lung cancer patients. Thus, this work is a launching avenue for others upon which to build more evidence-based practice in the care of lung cancer patients. Contemporary Issues in Lung Cancer, Second Edition, is divided into six ...
... lung cancer patients. Thus, this work is a launching avenue for others upon which to build more evidence-based practice in the care of lung cancer patients. Contemporary Issues in Lung Cancer, Second Edition, is divided into six ...
Page 6
Marilyn Haas. Age at Time of Lung Cancer Diagnosis/Death Table 1–4 Stage Distribution at Lung Cancer Diagnosis Time ... patients in comparison to the general population) 5-Year Survival Rate Overall 15.2% Caucasian males 13.4% Caucasian ...
Marilyn Haas. Age at Time of Lung Cancer Diagnosis/Death Table 1–4 Stage Distribution at Lung Cancer Diagnosis Time ... patients in comparison to the general population) 5-Year Survival Rate Overall 15.2% Caucasian males 13.4% Caucasian ...
Page 7
Marilyn Haas. Table 1–4 Stage Distribution at Lung Cancer Diagnosis Time at Diagnosis 5-Year Survival Rates Local 16 ... patients with cancer. In 1977, the AJCC began publication of the AJCC Cancer ... cancer staging Lung Cancer Staging 7.
Marilyn Haas. Table 1–4 Stage Distribution at Lung Cancer Diagnosis Time at Diagnosis 5-Year Survival Rates Local 16 ... patients with cancer. In 1977, the AJCC began publication of the AJCC Cancer ... cancer staging Lung Cancer Staging 7.
Page 8
... tumor-nodes-metastasis (TNM) staging classification in Table 1–6 has shown significance and has proven to be beneficial for predicting survival in patients with NSCLC, the TNM staging system does not have the same prognostic ...
... tumor-nodes-metastasis (TNM) staging classification in Table 1–6 has shown significance and has proven to be beneficial for predicting survival in patients with NSCLC, the TNM staging system does not have the same prognostic ...
Page 12
... healthcare professionals, pa- tients, and the public, including information from PDQ about cancer treatment, screening, prevention, genetics, supportive care, 12 Chapter 1: Separating Out the Differences Between Lung Cancers.
... healthcare professionals, pa- tients, and the public, including information from PDQ about cancer treatment, screening, prevention, genetics, supportive care, 12 Chapter 1: Separating Out the Differences Between Lung Cancers.
Contents
Oncology Treatment Modalities | 45 |
Special Issues Facing Individuals with Lung Cancer | 117 |
Psychosocial Issues of Individuals with Lung Cancer | 231 |
Assistance and Resources for Individuals Facing Lung Cancer | 255 |
Media and Future Research Directions | 301 |
Index | 353 |
Other editions - View all
Common terms and phrases
adjuvant agents aprepitant associated bevacizumab breathing breathlessness Bruera carboplatin carcinoma cell lung cancer chemotherapy chronic cisplatin Clinical Oncology clinical trials combination diagnosis disease docetaxel dose drug dyspnea EGFR erlotinib etoposide evaluation evidence-based factors fatigue gefitinib gemcitabine gene improve increased individuals indoor radon Internet intervention irinotecan Journal of Clinical lung cancer patients Medicine ment metastatic months NCCN nicotine non-small cell lung NSCLC Nursing Forum Oncology Nursing Oncology Nursing Forum paclitaxel palliative palliative care patient navigation patients and families patients with lung pemetrexed phase postoperative potential pulmonary quit smoking radiation therapy radiotherapy radon randomized receptors regimen reported resection respiratory response rate risk role SCLC score screening Sekido side effects small cell lung smoking cessation stage strategies support group surgical survival rate Symptom Management Table tients tion tobacco topotecan toxicity treat treatment tumor versus vinorelbine weight loss